• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Adaptive Biotechnologies Corporation - Common Stock (NQ:ADPT)

    13.91 +0.04 (+0.29%)
    Streaming Delayed Price Updated: 12:43 PM EDT, May 22, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 358,424
    Open 14.00
    Bid (Size) 13.90 (200)
    Ask (Size) 13.92 (700)
    Prev. Close 13.87
    Today's Range 13.73 - 14.27
    52wk Range 8.500 - 20.76
    Shares Outstanding 144,311,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive (ADPT) Q1 2026 Earnings Transcript ↗
    Adaptive (ADPT) Q1 2026 Earnings Transcript 
    Via The Motley Fool

    Performance

    YTD
    -12.6%
    -12.6%
    1 Month
    -2.1%
    -2.1%
    3 Month
    -13.3%
    -13.3%
    6 Month
    -14.8%
    -14.8%
    1 Year
    +53.0%
    +53.0%

    More News

    Read More
    Adaptive Biotechnologies (NASDAQ:ADPT) Surges 6% on Q1 Beat and Raised MRD Guidance ↗
    Via Chartmill
    Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
    Via Chartmill
    Adaptive Biotechnologies (NASDAQ:ADPT) Reports Strong Q4 Revenue Beat and Path to Profitability ↗
    Via Chartmill
    News headline image
    Adaptive Biotechnologies Reports First Quarter 2026 Financial Results
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies' Chief Operating Officer Sold Over 19,000 Company Shares. Here's What That Means for Investors. ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Adaptive Biotechnologies' COO Is Running a Systematic Sell Program — Here's What It Means ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Should You Sell Adaptive Biotechnologies (ADPT) After Its President and COO Sold 57,000 Shares? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Adaptive Biotech's President Trimmed Her Position. But what Remains is worth a look ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Adaptive Biotech Insider Sale of 180,000 Shares Tied to Tax Event as Stock Jumps 70% in a Year ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Adaptive Biotechnologies Insider Sells $1 Million in Stock After a Doubling in Share Price ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Adaptive Biotech (ADPT) Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies Surges as Preliminary 2025 Results Signal a Turning Point in MRD Commercialization
    Via MarketMinute
    News headline image
    Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    The Year-End Biotech Chill: Adaptive Biotechnologies Braces for J.P. Morgan Crucible Amid Market Sell-Off
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease
    From Adaptive Biotechnologies
    Via GlobeNewswire
    News headline image
    Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
    From Adaptive Biotechnologies
    Via GlobeNewswire

    Frequently Asked Questions

    Is Adaptive Biotechnologies Corporation - Common Stock publicly traded?
    Yes, Adaptive Biotechnologies Corporation - Common Stock is publicly traded.
    What exchange does Adaptive Biotechnologies Corporation - Common Stock trade on?
    Adaptive Biotechnologies Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Adaptive Biotechnologies Corporation - Common Stock?
    The ticker symbol for Adaptive Biotechnologies Corporation - Common Stock is ADPT on the Nasdaq Stock Market
    What is the current price of Adaptive Biotechnologies Corporation - Common Stock?
    The current price of Adaptive Biotechnologies Corporation - Common Stock is 13.91
    When was Adaptive Biotechnologies Corporation - Common Stock last traded?
    The last trade of Adaptive Biotechnologies Corporation - Common Stock was at 05/22/26 12:43 PM ET
    What is the market capitalization of Adaptive Biotechnologies Corporation - Common Stock?
    The market capitalization of Adaptive Biotechnologies Corporation - Common Stock is 2.01B
    How many shares of Adaptive Biotechnologies Corporation - Common Stock are outstanding?
    Adaptive Biotechnologies Corporation - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.